Pancreatic cancer circulating tumor cells: applications for personalized oncology

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
   PubMed Web of Science ®Google Scholar
• Rahib, L., Smith, B.D., Aizenberg, R., et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–2921.
   PubMed Web of Science ®Google Scholar
• Wong, M.C.S., Jiang, J. Y., Liang, M., et al. Global temporal patterns of pancreatic cancer and association with socioeconomic development. Sci Rep. 2017;7(1):3165.
   PubMedGoogle Scholar
• Noone AM, Krapcho M, Miller D, et al., eds. SEER cancer statistics review, 1975–2015, based on November 2017 SEER data submission, posted to the SEER web site. Bethesda, MD: National Cancer Institute; 2018 cited Apr.
   Google Scholar
• Allen, P.J., Kuk, D., Castillo, C.F.D., et al. Multi-institutional validation study of the American Joint Commission on Cancer (8th Edition) changes for T and N staging in patients with pancreatic adenocarcinoma. Ann Surg. 2017;265(1):185–191.
   PubMed Web of Science ®Google Scholar
• Yermilov, I., Bentrem, D., Sekeris, E., et al. Readmissions following pancreaticoduodenectomy for pancreas cancer: a population-based appraisal. Ann Surg Oncol. 2009;16(3):554–561.
   PubMed Web of Science ®Google Scholar
• Mokdad, A.A., Minter, R. M., Zhu, H., et al. Neoadjuvant therapy followed by resection versus upfront resection for resectable pancreatic cancer: a propensity score matched analysis. J Clin Oncol. 2017;35(5):515–522.
   PubMed Web of Science ®Google Scholar
• Ashworth T. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J. 1869;14(3):146–149.
   Google Scholar
• Massague J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature. 2016;529(7586):298–306.
   PubMed Web of Science ®Google Scholar
• Poruk, K.E., Blackford, A.L., Griffin, J.F., et al. Circulating tumor cell phenotype predicts recurrence and survival in pancreatic adenocarcinoma. Ann Surg. 2016;264(6):1073–1081.
   PubMed Web of Science ®Google Scholar
• Rhim, A.D., Mirek, E. T., Aiello, N. M., et al. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148(1–2):349–361.
   PubMed Web of Science ®Google Scholar
• Alix-Panabieres C, Pantel K. Challenges in circulating tumour cell research. Nat Rev Cancer. 2014;14(9):623–631.
   PubMed Web of Science ®Google Scholar
• Aceto, N., Bardia, A., Miyamoto, D. T., et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158(5):1110–1122.
   PubMed Web of Science ®Google Scholar
• Heller, G., McCormack, R., Kheoh, T., et al. Circulating tumor cell number as a response measure of prolonged survival for metastatic castration-resistant prostate cancer: a comparison with prostate-specific antigen across five randomized phase III clinical trials. J Clin Oncol. 2018;36(6):572–580.
   PubMedGoogle Scholar
• Xu, T., Shen, G., Cheng, M., et al. Clinicopathological and prognostic significance of circulating tumor cells in patients with lung cancer: a meta-analysis. Oncotarget. 2017;8(37):62524–62536.
   PubMedGoogle Scholar
• Bidard, F.C., Michiels, S., Riethdorf, S., et al. Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: A meta-analysis. J Natl Cancer Inst. 2018.
   PubMedGoogle Scholar
• Krebs, M.G., Sloane, R., Priest, L., et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol. 2011;29(12):1556–1563.
   PubMed Web of Science ®Google Scholar
• Yan, W.T., Cui, X., Chen, Q., et al. Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis. Sci Rep. 2017;7:43464.
   PubMed Web of Science ®Google Scholar
• Hall, C.S., Karhade, M. G., Bauldry, J. B. B., et al. Prognostic value of circulating tumor cells identified before surgical resection in nonmetastatic breast cancer patients. J Am Coll Surg. 2016;223(1):20–29.
   PubMed Web of Science ®Google Scholar
• Sharma, S., Zhuang, R., Long, M., et al. Circulating tumor cell isolation, culture, and downstream molecular analysis. Biotechnol Adv. 2018;36(4):1063–1078.
   PubMed Web of Science ®Google Scholar
• Bhagwat, N., Dulmage, K., Pletcher, C. H., et al. An integrated flow cytometry-based platform for isolation and molecular characterization of circulating tumor single cells and clusters. Sci Rep. 2018;8(1):5035.
   PubMedGoogle Scholar
• Vona, G., Sabile, A., Louha, M., et al. Isolation by size of epithelial tumor cells. Am J Pathol. 2000;156(1):57–63.
   PubMed Web of Science ®Google Scholar
• Gupta, V., Jafferji, I., Garza, M., et al. ApoStream(), a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood. Biomicrofluidics. 2012;6(2):24133.
   PubMed Web of Science ®Google Scholar
• Karabacak, N.M., Spuhler, P. S., Fachin, F., et al. Microfluidic, marker-free isolation of circulating tumor cells from blood samples. Nat Protoc. 2014;9(3):694–710.
   PubMed Web of Science ®Google Scholar
• Jan, Y.J., Chen, J. F., Zhu, Y., et al. NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells. Adv Drug Deliv Rev. 2018;125:78–93.
   PubMed Web of Science ®Google Scholar
• Alix-Panabieres, C., Brouillet, J. P., Fabbro, M., et al. Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients. J Immunol Methods. 2005;299(1–2):177–188.
   PubMed Web of Science ®Google Scholar
• Friedlander, T.W., T. W., Ngo, V. T., Dong, et al. Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer. Int J Cancer. 2014;134(10):2284–2293.
   PubMed Web of Science ®Google Scholar
• Saucedo-Zeni, N., Mewes, S., Niestroj, R., et al. A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire. Int J Oncol. 2012;41(4):1241–1250.
   PubMed Web of Science ®Google Scholar
• Fischer, J.C., Niederacher, D., Topp, S.A., et al. Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients. Proc Natl Acad Sci U S A. 2013;110(41):16580–16585.
   PubMed Web of Science ®Google Scholar
• Luk, A.W.S., Ma, Y., Ding, P. N., et al., CTC-mRNA (AR-V7) analysis from blood samples-impact of blood collection tube and storage time. Int J Mol Sci. 2017;18(5).
   Web of Science ®Google Scholar
• Ilie, M., Hofman, V., Leroy, S., et al. Use of circulating tumor cells in prospective clinical trials for NSCLC patients - standardization of the pre-analytical conditions. Clin Chem Lab Med. 2018;56(6):980–989.
   PubMed Web of Science ®Google Scholar
• Qin, J., Alt, J. R., Hunsley, B. A., et al. Stabilization of circulating tumor cells in blood using a collection device with a preservative reagent. Cancer Cell Int. 2014;14(1):23.
   PubMed Web of Science ®Google Scholar
• Ilie, M., Hofman, V., Long, E.,et al. Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine? Ann Transl Med. 2014;2(11):107.
   PubMedGoogle Scholar
• Stefansson, S., Adams, D. L., Ershler, W. B., et al. A cell transportation solution that preserves live circulating tumor cells in patient blood samples. BMC Cancer. 2016;16:300.
   PubMed Web of Science ®Google Scholar
• Brychta, N., Drosch, M., Driemel, C., et al. Isolation of circulating tumor cells from pancreatic cancer by automated filtration. Oncotarget. 2017;8(49):86143–86156.
   PubMedGoogle Scholar
• Court, C.M., Sho, S., Hou, S., et al. Reality of single circulating tumor cell sequencing for molecular diagnostics in pancreatic cancer. J Mol Diagn. 2016;18(5):688–696.
   PubMed Web of Science ®Google Scholar
• Miyamoto, D.T., Zheng, Y., Wittner, B. S., et al. RNA-Seq of single prostate CTCs implicates noncanonical WNT signaling in antiandrogen resistance. Science. 2015;349(6254):1351–1356.
   PubMed Web of Science ®Google Scholar
• Carter, L., Rothwell, D. G., Mesquita, B., et al. Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer. Nat Med. 2017;23(1):114–119.
   PubMed Web of Science ®Google Scholar
• Baslan T, Hicks J. Unravelling biology and shifting paradigms in cancer with single-cell sequencing. Nat Rev Cancer. 2017;17(9):557–569.
   PubMed Web of Science ®Google Scholar
• Salvianti F, Pinzani P. The diagnostic potential of mutation detection from single circulating tumor cells in cancer patients. Expert Rev Mol Diagn. 2017;17(11):975–981.
   PubMed Web of Science ®Google Scholar
• Sho, S., Winograd, P., Lee, S., et al. Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications. BMC Cancer. 2017;17(1):457.
   PubMedGoogle Scholar
• Court, C.M., Ankeny, J. S., Hou, S., et al. Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis. Expert Rev Mol Diagn. 2015;15(11):1491–1504.
   PubMed Web of Science ®Google Scholar
• Soeth, E., Grigoleit, U., Moellmann, B., et al. Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival. J Cancer Res Clin Oncol. 2005;131(10):669–676.
   PubMed Web of Science ®Google Scholar
• Hoffmann, K., Kerner, C., Wilfert, W., et al. Detection of disseminated pancreatic cells by amplification of cytokeratin-19 with quantitative RT-PCR in blood, bone marrow and peritoneal lavage of pancreatic carcinoma patients. World J Gastroenterol. 2007;13(2):257–263.
   PubMed Web of Science ®Google Scholar
• Sergeant, G., Roskams, T., van Pelt, J., et al. Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma. BMC Cancer. 2011;11:47.
   PubMed Web of Science ®Google Scholar
• Mataki, Y., Takao, S., Maemura, K.,et al. Carcinoembryonic antigen messenger RNA expression using nested reverse transcription-PCR in the peripheral blood during follow-up period of patients who underwent curative surgery for biliary-pancreatic cancer: longitudinal analyses. Clin Cancer Res. 2004;10(11):3807–3814.
   PubMed Web of Science ®Google Scholar
• Uchikura, K., Takao, S., Nakajo, A., et al. Intraoperative molecular detection of circulating tumor cells by reverse transcription-polymerase chain reaction in patients with biliary-pancreatic cancer is associated with hematogenous metastasis. Ann Surg Oncol. 2002;9(4):364–370.
   PubMed Web of Science ®Google Scholar
• De Albuquerque, A., Kubisch, I., Breier, G., et al. Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study. Oncology. 2012;82(1):3–10.
   PubMed Web of Science ®Google Scholar
• Zhou, J., Hu, L., Yu, Z., et al. Marker expression in circulating cancer cells of pancreatic cancer patients. J Surg Res. 2011;171(2):631–636.
   PubMed Web of Science ®Google Scholar
• Kurihara, T., Itoi, T., Sofuni, A., et al. Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result. J Hepatobiliary Pancreat Surg. 2008;15(2):189–195.
   PubMedGoogle Scholar
• Bidard, F.C., Huguet, F., Louvet, C., et al. Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. Ann Oncol. 2013;24(8):2057–2061.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Wang, F., Ning, N., et al. Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer. Int J Cancer. 2015;136(5):1228–1233.
   PubMed Web of Science ®Google Scholar
• Khoja, L., Backen, A., Sloane, R., et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106(3):508–516.
   PubMed Web of Science ®Google Scholar
• Okubo, K., Uenosono, Y., Arigami, T., et al. Clinical impact of circulating tumor cells and therapy response in pancreatic cancer. Eur J Surg Oncol. 2017;43(6):1050–1055.
   PubMed Web of Science ®Google Scholar
• Sefrioui, D., Blanchard, F., Toure, E., et al. Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours. Br J Cancer. 2017;117(7):1017–1025.
   PubMed Web of Science ®Google Scholar
• Stephenson, D., Nahm, C., Chua, T., et al. Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis. Oncotarget. 2017;8(63):107223–107236.
   PubMedGoogle Scholar
• Ankeny, J.S., Court, C. M., Hou, S., et al. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer. Br J Cancer. 2016;114(12):1367–1375.
   PubMed Web of Science ®Google Scholar
• Court, C.M., Sho, S., Winograd, P., et al. Circulating tumor cells predict occult metastatic disease and prognosis in pancreatic cancer. Ann Surg Oncol. 2018;25(4):1000–1008.
   PubMed Web of Science ®Google Scholar
• Effenberger, K.E., Schroeder, C., Hanssen, A., et al. Improved risk stratification by circulating tumor cell counts in pancreatic cancer. Clin Cancer Res. 2018.
   PubMed Web of Science ®Google Scholar
• Yu, K.H., Ricigliano, M., Hidalgo, M., et al. Pharmacogenomic modeling of circulating tumor and invasive cells for prediction of chemotherapy response and resistance in pancreatic cancer. Clin Cancer Res. 2014;20(20):5281–5289.
   PubMed Web of Science ®Google Scholar
• Krantz BA, O’Reilly EM. Biomarker-based therapy in pancreatic ductal adenocarcinoma: an emerging reality? Clin Cancer Res. 2018;24(10):2241–2250.
   PubMed Web of Science ®Google Scholar
• Yu, M., Ting, D. T., Stott, S. L., et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature. 2012;487(7408):510–513.
   PubMed Web of Science ®Google Scholar
• Dotan, E., Alpaugh, R. K., Ruth, K., et al. Prognostic significance of MUC-1 in circulating tumor cells in patients with metastatic pancreatic adenocarcinoma. Pancreas. 2016;45(8):1131–1135.
   PubMed Web of Science ®Google Scholar
• Gemenetzis G, Yu GV, Ding J et al. Circulating Tumor Cells Dynamics in Pancreatic Adenocarcinoma Correlate with Disease Status: Data from a Prospective Trial, in American Surgical Association 138th Annual Meeting. 2018: Phoenix, AZ.
   Google Scholar
• Poruk, K.E., Blackford, A.L., Weiss, M.J., et al. Circulating tumor cells expressing markers of tumor-initiating cells predict poor survival and cancer recurrence in patients with pancreatic ductal adenocarcinoma. Clin Cancer Res. 2017;23(11):2681–2690.
   PubMed Web of Science ®Google Scholar
• Rasheed, Z.A., Yang, J., Wang, Q., et al. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. J Natl Cancer Inst. 2010;102(5):340–351.
   PubMedGoogle Scholar
• Hou, Y.C., Chao, Y. J., Tung, H. L., et al. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma. Cancer. 2014;120(17):2766–2777.
   PubMed Web of Science ®Google Scholar
• Aktas, B., Tewes, M., Fehm, T., et al. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res. 2009;11(4):R46.
   PubMed Web of Science ®Google Scholar
• Li, M., Zhang, B., Zhang, Z., et al. Stem cell-like circulating tumor cells indicate poor prognosis in gastric cancer. Biomed Res Int. 2014;2014:981261.
   PubMed Web of Science ®Google Scholar
• Kulemann, B., Rösch, S., Seifert, S., et al. Pancreatic cancer: circulating tumor cells and primary tumors show heterogeneous KRAS mutations. Sci Rep. 2017;7(1):4510.
   PubMedGoogle Scholar
• Sho, S., Kim, S., Braxton, D. R., et al. Digital PCR improves mutation analysis in pancreas fine needle aspiration biopsy specimens. PLoS One. 2017;12(1):e0170897.
   PubMed Web of Science ®Google Scholar
• Maheswaran S, Haber DA. Ex vivo culture of CTCs: an emerging resource to guide cancer therapy. Cancer Res. 2015;75(12):2411–2415.
   PubMed Web of Science ®Google Scholar
• Ameri, K., Luong, R., Zhang, H., et al. Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype. Br J Cancer. 2010;102(3):561–569.
   PubMed Web of Science ®Google Scholar
• Zhang, L., Ridgway, L. D., Wetzel, M. D., et al. The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci Transl Med. 2013;5(180):180ra48.
   PubMed Web of Science ®Google Scholar
• Yu, M., Bardia, A., Aceto, N., et al. Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science. 2014;345(6193):216–220.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., Shiratsuchi, H., Lin, J., et al. Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model. Oncotarget. 2014;5(23):12383–12397.
   PubMed Web of Science ®Google Scholar
• Khoo, B.L., Lee, S. C., Kumar, P., et al. Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy. Oncotarget. 2015;6(17):15578–15593.
   PubMedGoogle Scholar
• Khoo, B.L., Grenci, G., Lim, Y. B., et al. Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device. Nat Protoc. 2018;13(1):34–58.
   PubMed Web of Science ®Google Scholar
• Khoo, B.L., Grenci, G., Jing, T., et al. Liquid biopsy and therapeutic response: circulating tumor cell cultures for evaluation of anticancer treatment. Sci Adv. 2016;2(7):e1600274.
   PubMed Web of Science ®Google Scholar
• Boj, S.F., Hwang, C. I., Baker, L. A., et al. Organoid models of human and mouse ductal pancreatic cancer. Cell. 2015;160(1–2):324–338.
   PubMed Web of Science ®Google Scholar
• Broutier, L., Andersson-Rolf, A., Hindley, C. J., et al. Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation. Nat Protoc. 2016;11(9):1724–1743.
   PubMed Web of Science ®Google Scholar
• Es, H.A, Montazeri, L., Aref, A. R., et al. Personalized cancer medicine: an organoid approach. Trends Biotechnol. 2018;36(4):358–371.
   PubMed Web of Science ®Google Scholar
• Vlachogiannis, G., Hedayat, S., Vatsiou, A., et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science. 2018;359(6378):920–926.
   PubMed Web of Science ®Google Scholar
• Aberle, M.R., Burkhart, R. A., Tiriac, H., et al. Patient-derived organoid models help define personalized management of gastrointestinal cancer. Br J Surg. 2018;105(2):e48–e60.
   PubMed Web of Science ®Google Scholar
• Haber DA, Velculescu VE. Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA. Cancer Discov. 2014;4(6):650–661.
   PubMed Web of Science ®Google Scholar